Sodium iodide (131I) is an important iodine-based radiopharmaceutical used in medical imaging and radiation therapy. It is most commonly used as a diagnostic imaging agent in nuclear medicine. 131I emits gamma radiation which can be detected by a gamma camera and used to create images of the organs and tissues of the body. It is also used to treat thyroid cancer, hyperthyroidism and Graves’ disease. 131I is a radioactive isotope of iodine, a trace element found naturally in the environment. It is a soluble form of iodine which is taken up by the thyroid gland and used in the production of thyroid hormones. 131I has a half-life of 8 days and emits gamma radiation.
Sodium iodide (131I), also known as radioiodine-131, is a radioactive isotope of iodine used for both diagnostic and therapeutic purposes in nuclear medicine. Here's a breakdown of its key aspects:
Main Functions:
- Diagnosis: Similar to sodium iodide (123I), it can be used for imaging and function testing of the thyroid gland. However, due to its longer half-life, it's less commonly used for diagnostic purposes nowadays.
- Treatment: The primary function of sodium iodide (131I) is in the treatment of certain thyroid conditions:
- Hyperthyroidism: By destroying overactive thyroid tissue, it can help regulate hormone production in cases of an overactive thyroid gland.
- Thyroid Cancer: For some types of well-differentiated thyroid cancers, sodium iodide (131I) can target and destroy cancerous thyroid cells or remnant thyroid tissue after surgery.
Applications:
- Treatment of Graves' Disease: A common cause of hyperthyroidism.
- Treatment of Toxic Multinodular Goiter: A condition with enlarged thyroid nodules causing hyperthyroidism.
- Ablation of Thyroid Tissue After Surgery: For differentiated thyroid cancer, it can help destroy any remaining thyroid tissue and potentially reduce the risk of recurrence.
Advantages and Disadvantages:
- Targeted Therapy: Sodium iodide (131I) specifically targets thyroid tissue due to the gland's natural iodine uptake.
- Effective Treatment: It can be a very effective treatment for hyperthyroidism and some thyroid cancers.
- Long Half-Life (8 days): While this allows for sustained therapeutic effects, it also leads to a longer radiation exposure compared to sodium iodide (123I).
Important Considerations:
- Radioactive Material: Significant radiation exposure is a major drawback. Pregnant and breastfeeding women, and people with certain health conditions, will not be candidates for this treatment due to the risks.
- Precautions and Monitoring: Special precautions are needed after treatment to minimize radiation exposure to others. Patients may need to be hospitalized for a short period depending on the dose administered. Thyroid function will be closely monitored after treatment.
- Potential Side Effects: Nausea, vomiting, fatigue, and dry mouth are common side effects. In rare cases, damage to salivary glands or taste buds can occur.
- Alternatives: Other medications, surgery, or ablation with other isotopes like radioactive iodine-125 might be considered depending on the specific condition and patient factors.